Skip to main content
. 2024 Mar 27;9(5):457–465. doi: 10.1001/jamacardio.2024.0284

Table 2. Model Performance With and Without N-Terminal Pro–Brain Natriuretic Peptide (NT-proBNP) Level Assessed by Harrell C Statistic.

C statistic (95% CI) Difference in C statistic (95% CI)
(1) NT-proBNP alone (2) Baseline model without NT-proBNP (3) Baseline model with NT-proBNP (2) vs (1) P value (3) vs (1) P value
HFH/CV death
1 y 0.66 (0.64 to 0.68) 0.70 (0.68 to 0.72) 0.73 (0.71 to 0.75) 0.04 (0.01 to 0.06) .01 0.07 (0.05 to 0.09) <.001
2 y 0.65 (0.63 to 0.66) 0.68 (0.66 to 0.70) 0.71 (0.69 to 0.73) 0.03 (0.01 to 0.05) .009 0.06 (0.05 to 0.08) <.001
CV death
1 y 0.69 (0.65 to 0.73) 0.72 (0.68 to 0.76) 0.75 (0.71 to 0.79) 0.03 (−0.02 to 0.08) .24 0.06 (0.03 to 0.09) <.001
2 y 0.65 (0.62 to 0.68) 0.69 (0.66 to 0.71) 0.71 (0.68 to 0.74) 0.04 (0 to 0.07) .03 0.06 (0.04 to 0.08) <.001
All-cause death
1 y 0.65 (0.62 to 0.68) 0.68 (0.65 to 0.71) 0.71 (0.68 to 0.74) 0.02 (−0.01 to 0.06) .22 0.05 (0.03 to 0.07) <.001
2 y 0.62 (0.60 to 0.64) 0.66 (0.64 to 0.68) 0.68 (0.66 to 0.70) 0.04 (0.02 to 0.06) <.001 0.06 (0.04 to 0.07) <.001

Abbreviations: CV, cardiovascular; HFH, heart failure hospitalization.